Skip to main content

Adhesive Wear Time

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Baxter
BaxterCosta Rica - Cartago
2 programs
AdhesiveN/A2 trials
Battrode AdhesiveN/A
Active Trials
NCT07256951Recruiting30Est. May 2026
NCT06777446Not Yet Recruiting380Est. Feb 2034
Baxter International
1 program
AdhesiveN/A

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
2029
2030
2031
BaxterAdhesive
BaxterAdhesive

Clinical Trials (2)

Total enrollment: 410 patients across 2 trials

Gen 2 Battrode Wear Study

Start: Nov 2025Est. completion: May 202630 patients
N/ARecruiting

Elective Adhesiolysis vs. a Wait-and-see Policy to Prevent Recurrences After Conservative Treatment of Adhesive Small Bowel Obstruction

Start: Feb 2025Est. completion: Feb 2034380 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 410 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.